Skip to main content

Advertisement

SpringerLink
Log in

A comprehensive review of childbearing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

  • Review
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

Our aim is to present a review on childbearing following CRS and HIPEC for peritoneal malignancy.

Methods

A review of the English literature, up to December 2019, was conducted, using PubMed/MEDLINE, EmBase and Google Scholar bibliographic databases, following the MOOSE guidelines. The terms “Cytoreductive Surgery”, “Hyperthermic Intraperitoneal Chemotherapy”, “Peritoneal Carcinomatosis”, “Pregnancy”, “Fertility Preservation”, “Conception” were used. All study designs were eligible for inclusion in the final analysis.

Results

In total, 7 studies (5 case reports and 2 case series) were included in the final analysis, reporting on 14 successful pregnancies after CRS and HIPEC. The mean age of patients at the time of CRS/HIPEC was 28.8 ± 5.9 years (range 18–36), while the mean interval between CRS/HIPEC and pregnancy was 29.6 ± 20.3 months (range 9–80 months). Nine patients were treated for pseudomyxoma peritonei, four for primary peritoneal mesothelioma and one for endocrine carcinoma. Mean Peritoneal Carcinomatosis Index was 9.8 ± 7.8 (range 1–26). All patients underwent fertility-sparing CRS (preservation of at least one ovary and the uterus). In 12 cases, conception was spontaneous, whereas two pregnancies were achieved through in-vitro fertilization. One patient developed gestational hypertension, while two labors were preterm. Mean disease-free survival was 64.1 months (range 24–106 months).

Conclusion

A successful pregnancy is feasible in selected patients, after CRS and HIPEC. Assisted reproduction techniques (IVF using frozen oocytes or frozen embryos, ovarian tissue cryopreservation, preoperative treatment with GnRH analogs) should be discussed pre-operatively with the patient, without, however, compromising overall survival or risking locoregional recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Benhaim L, Faron M, Gelli M, Sourrouille I, Honoré C, Delhorme JB, Elias D, Goere D (2019) Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei. Surg Oncol 29:78–83. https://doi.org/10.1016/j.suronc.2019.03.004

    Article  PubMed  Google Scholar 

  2. Eng OS, Turaga KK (2019) Cytoreduction and hyperthermic intraperitoneal chemotherapy in metastatic colorectal cancer. J Surg Oncol 119:613–615. https://doi.org/10.1002/jso.25438

    Article  PubMed  Google Scholar 

  3. van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh IHJT, van der Velden J, Arts HJ, Massuger LFAG, Aalbers AGJ, Verwaal VJ, Kieffer JM, Van de Vijver KK, van Tinteren H, Aaronson NK, Sonke GS (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 378:230–240. https://doi.org/10.1056/NEJMoa1708618

    Article  PubMed  Google Scholar 

  4. Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, Gilly FN, Levine EA, Shen P, Mohamed F, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27:6237–6242. https://doi.org/10.1200/JCO.2009.23.9640

    Article  PubMed  Google Scholar 

  5. González-Moreno S, Kusamura S, Baratti D, Deraco M (2008) Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy. J Surg Oncol 98:237–241. https://doi.org/10.1002/jso.21072

    Article  PubMed  Google Scholar 

  6. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, Group for the MOOS in E (MOOSE) (2000) Meta-analysis of Observational Studies in Epidemiology. A Proposal for Reporting. JAMA 283:2008–2012. https://doi.org/10.1001/jama.283.15.2008

  7. Ortega-Deballon P, Glehen O, Levine E, Piso P, Sugarbaker PH, Hayes-Jordan A, Facy A, Bakrin N, Rat P (2011) Childbearing after hyperthermic intraperitoneal chemotherapy: Results from an international survey. Ann Surg Oncol 18:2297–2301. https://doi.org/10.1245/s10434-011-1595-5

    Article  PubMed  PubMed Central  Google Scholar 

  8. Elias D, Duchalais E, Dartigues P, Duvillard P, Poirot C, Goéré D (2013) A new policy regarding ovarian resection in young women treated for peritoneal carcinomatosis. Ann Surg Oncol 20:1837–1842. https://doi.org/10.1245/s10434-013-2879-8

    Article  PubMed  Google Scholar 

  9. Spears N, Lopes F, Stefansdottir A, Rossi V, De FM, Anderson RA, Klinger FG (2019) Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update 25:673–693. https://doi.org/10.1093/humupd/dmz027

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, Kusamura S (2004) Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 11:393–398. https://doi.org/10.1245/ASO.2004.07.002

    Article  PubMed  Google Scholar 

  11. Kyser K, Bidus MA, Rodriguez M, Rose GS, Elkas JC (2006) Spontaneous pregnancy following cytoreduction with peritonectomy and hyperthermic intraperitoneal chemotherapy. Gynecol Oncol 100:198–200. https://doi.org/10.1016/j.ygyno.2005.08.045

    Article  PubMed  Google Scholar 

  12. Morgan S, Anderson RA, Gourley C, Wallace WH, Spears N (2012) How do chemotherapeutic agents damage the ovary? Hum Reprod Update. https://doi.org/10.1093/humupd/dms022

    Article  PubMed  Google Scholar 

  13. Paz MM, Zhang X, Lu J, Holmgren A (2012) A New Mechanism of action for the anticancer drug mitomycin C: mechanism-based inhibition of thioredoxin reductase. Chem Res Toxicol 25:1502–1511

    Article  CAS  Google Scholar 

  14. Hyman JH, Tulandi T (2013) Fertility preservation options after gonadotoxic chemotherapy. Clin Med Insights Reprod Heal. https://doi.org/10.4137/CMRH.S10848

    Article  Google Scholar 

  15. Cianos R, Lafever S, Mills N (2013) Heated intraperitoneal chemotherapy in appendiceal cancer treatment. Clin J Oncol Nurs 17:84–87. https://doi.org/10.1188/13.CJON.84-87

    Article  PubMed  Google Scholar 

  16. Campanati RG, Hanan B, de Souza SS, Gomes da Silva R (2014) Pregnancy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei. Case Rep Surg 2014:1–3. https://doi.org/10.1155/2014/694912

    Article  Google Scholar 

  17. de Assis V, Saunders R (2019) In vitro fertilization pregnancy following treatment of diffuse malignant peritoneal mesothelioma. J Case Rep Images Obstet Gynecol 5:1. https://doi.org/10.5348/100043z08va2019cr

    Article  Google Scholar 

  18. Bocca SM, Perry R, Oehninger S (2005) Pseudomyxoma peritonei: a rare differential diagnosis of hydrosalpinx. Fertil Steril 84:1017.e1–1017.e2. https://doi.org/10.1016/j.fertnstert.2005.05.016

    Article  Google Scholar 

  19. Hartnett KP, Mertens AC, Kramer MR, Lash TL, Spencer JB, Ward KC, Howards PP (2018) Pregnancy after cancer: does timing of conception affect infant health? Cancer 124:4401–4407. https://doi.org/10.1002/cncr.31732

    Article  PubMed  Google Scholar 

  20. Tan GHC, Chia CS, Tan SH, Soo KC, Teo MCC (2018) Early recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Int J Clin Oncol 23:989–998. https://doi.org/10.1007/s10147-018-1301-8

    Article  CAS  PubMed  Google Scholar 

  21. Mercier F, Dagbert F, Pocard M et al (2019) Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. BJS Open 3:195–202. https://doi.org/10.1002/bjs5.97

    Article  CAS  PubMed  Google Scholar 

  22. Chen H, Xiao L, Li J, Cui L, Huang W (2019) Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD008018.pub3

    Article  PubMed  PubMed Central  Google Scholar 

  23. Blumenfeld Z, Evron A (2015) Preserving fertility when choosing chemotherapy regimens-the role of gonadotropin-releasing hormone agonists. Expert Opin Pharmacother 16:1009–1020. https://doi.org/10.1517/14656566.2015.1031654

    Article  CAS  PubMed  Google Scholar 

  24. Blumenfeld Z, Eckman A (2005) Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a. J Natl Cancer Inst Monogr. https://doi.org/10.1093/jncimonographs/lgi015

    Article  PubMed  Google Scholar 

  25. Pacheco BP, Méndez Ribas JM, Milone G, Fernández I, Kvicala R, Mila T, Di Noto A, Ortiz OC, Pavlovsky S (2001) Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report. Gynecol Oncol 81:391–397. https://doi.org/10.1006/gyno.2001.6181

    Article  CAS  Google Scholar 

  26. Haase E, Yoo D, Sugarbaker PH (2009) Management of appendiceal pseudomyxoma peritonei diagnosed during pregnancy. World J Surg Oncol. https://doi.org/10.1186/1477-7819-7-48

    Article  PubMed  PubMed Central  Google Scholar 

  27. Gold JS, Bayar S, Salem RR (2004) Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg 139:760–765. https://doi.org/10.1001/archsurg.139.7.760

    Article  PubMed  Google Scholar 

  28. Abdulamir AS, Hafidh RR, Bakar FA (2011) The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res 30:1–13. https://doi.org/10.1186/1756-9966-30-11

    Article  Google Scholar 

  29. Gómez-Portilla A, Olabarria I, Martín E et al (2015) Natural conception after fertility-conserving cytoreductive surgery (FCCRS) and heated intraperitoneal chemotherapy (HIPEC) with the oxaliplatin protocol: a case report. Int J Surg Res 4:4–6. https://doi.org/10.5923/j.surgery.20150401.02

Download references

Funding

The authors did not receive any kind of funding for this work.

Author information

Authors and Affiliations

  1. Department of Gynecology, Athens Naval and Veterans Hospital, 70, Deinokratous str, 11521, Athens, Greece

    Dimitrios Papageorgiou & Katerina Papakonstantinou

  2. 2nd Department of Surgery, Athens Naval and Veterans Hospital, Athens, Greece

    Dimitrios K. Manatakis

  3. 1st Department of Surgery, Athens Naval and Veterans Hospital, Athens, Greece

    Ioannis D. Kyriazanos

Authors
  1. Dimitrios Papageorgiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dimitrios K. Manatakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Katerina Papakonstantinou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ioannis D. Kyriazanos
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

DP: Project development, data collection, manuscript writing, DKM: Project development, data collection, manuscript writing, KP: Manuscript editing, IDK: manuscript editing, project supervision. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Dimitrios Papageorgiou.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent statement

No informed consent was needed, as all the studies included in this review are already published.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Papageorgiou, D., Manatakis, D.K., Papakonstantinou, K. et al. A comprehensive review of childbearing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Arch Gynecol Obstet 302, 793–799 (2020). https://doi.org/10.1007/s00404-020-05687-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-020-05687-z

Keywords

Search

Navigation